Basic Information
Sildenafil ratiopharm
Regulatory Information
EMEA/H/C/001080
Authorised
December 23, 2009
19
June 24, 2022
Company Information
Germany
Graf-Arco-Str. 3 D-89079 Ulm
ratiopharm GmbH
Drug Classification
Generic Medicine
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for sildenafil to be effective, sexual stimulation is required.
Overview Summary
This is a summary of the European public assessment report (EPAR) for sildenafil. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for sildenafil.